Financials
- Market Capitalization 1.74 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-3.02
주가매출액비율
0.98
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.29 USD | -4.95% | -6.75% | -23.19% | +28.69% | 1.75 B USD | ||
| 2029 | SEPN Septerna, Inc. - Common Stock | 36.31 USD | -3.33% | +1.79% | -6.08% | +64.97% | 1.69 B USD | ||
| 2037 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.52 USD | -7.65% | -16.94% | -0.15% | +103.12% | 1.69 B USD | ||
| 2055 | BHVN Biohaven Ltd. Common Shares | 11.42 USD | -3.22% | -3.71% | -9.37% | -32.59% | 1.72 B USD |